Samuel Kim, MD
Rheumatology · Lawrenceville, GANPI 1629386388
Payments from drug & device makers
Across 1,215 payments — averaging $19.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$6K
- AbbVie$4K
- Johnson & Johnson$2K
- Novartis$2K
- UCB, Inc.$1K
- AstraZeneca$918
- plus $7K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 279 | $6,460 |
| AbbVie | 208 | $4,199 |
| Johnson & Johnson(2 entities) | 117 | $2,389 |
| Novartis | 116 | $1,708 |
| UCB, Inc. | 77 | $1,411 |
| AstraZeneca(2 entities) | 39 | $918 |
| GSK | 52 | $900 |
| E.r. Squibb & Sons, L.L.C. | 50 | $809 |
| Radius Health, Inc. | 47 | $758 |
| Lilly USA, LLC | 33 | $606 |
| Pfizer | 34 | $580 |
| Mallinckrodt Hospital Products Inc. | 25 | $499 |
| Genentech USA, Inc. | 27 | $434 |
| Boehringer Ingelheim | 18 | $336 |
| Sobi, Inc | 15 | $275 |
| Sanofi | 13 | $267 |
| Aurinia Pharma U.S., Inc. | 11 | $220 |
| Pacira Therapeutics, Inc. | 9 | $195 |
| Organon | 8 | $105 |
| Mallinckrodt Enterprises LLC | 6 | $99 |
| Invivyd Inc | 3 | $90 |
| ANI Pharmaceuticals, Inc. | 3 | $63 |
| Novo Nordisk | 4 | $61 |
| Assertio Therapeutics, Inc. | 4 | $50 |
| CSL Behring | 2 | $50 |
| Hikma Pharmaceuticals USA | 3 | $41 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Sequel Med Tech, LLC | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Fresenius Kabi USA, LLC | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Sandoz | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $14 |
| Actelion Pharmaceuticals US, Inc. | 1 | $10 |
How this compares
$23,733 in reported general payments places this provider in the 80th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Lawrenceville
- Theresa Lawrence FordLawrenceville$2.9M
- Glenn ParrisLawrenceville$158K
- Cynthia ElliottLawrenceville$101K
- Madhurika SamakurLawrenceville$23K
- Byung BanLawrenceville$19K
- Zohair AhmedLawrenceville$15K
- Wambui MachuaAtlanta$1.8M
- Brent FlickingerGainesville$1.6M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.